You just read:

Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis

News provided by

Bausch Health Companies Inc.; Clearside Biomedical

Oct 23, 2019, 06:55 ET